Menu

Eli Lilly and Amgen announced refunds for 340B covered entities that purchased certain drugs in 2021.

Lilly Posts 340B Refund Notice for Insulin Product Humulin

June 21, 2024 Bella Czajkowski, National Correspondent Views

Drug manufacturer Eli Lilly announced a new round of refunds for Humulin, a brand-name insulin, following a 340B ceiling price [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Bella Czajkowski